Drug recall · November 28, 2018
Clopidogrel Tablets recall
Why: Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31
- Lots / codes
Lot #: T600530, Exp 11/18
- Quantity
- 4,212 (30-count blister pack)
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- U.S.A.nationwide
- Initiated
- November 7, 2018 · Voluntary: Firm initiated
- Classified
- November 27, 2018
- Reported
- November 28, 2018
- Ended
- May 19, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clopidogrel
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.